Officer and Employee Incentives through Operating Profit-Linked Stock Acquisition Rights
First written in FY2024-Q1. 2 of 5 entries say "Raised", first in FY2024. Latest entry: FY2026-H1.
The whole theme swung hardest in 2020: 2 of 16 companies on the "Worse" side.
6 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「In any fiscal year from the fiscal year ending September 2026 through the fiscal year ending September 2028, if the Company's operating profit meets any of the conditions set out in (a) through (c) below at least once, holders of the stock acquisition rights may exercise the granted stock acquisition rights up to the percentage specified for each item, referred to below as the "exercisable percentage."」
The performance-based conditions for the fiscal years ending September 2026 through September 2028, based on operating profit of ¥2.0 billion, ¥2.3 billion and ¥2.5 billion, continue to be stated. - FY2025RaisedAnnual report
「In any fiscal year from the fiscal year ending September 2026 through the fiscal year ending September 2028, if the Company's operating profit meets any of the conditions set out in (a) through (c) below at least once, holders of the stock acquisition rights may exercise the granted stock acquisition rights up to the percentage specified for each item. (a) If operating profit exceeds ¥2.0 billion: exercisable percentage of 30%; (b) if operating profit exceeds ¥2.3 billion: exercisable percentage of 80%; (c) if operating profit exceeds ¥2.5 billion: exercisable percentage of 100%.」
For the Series 8 Stock Acquisition Rights, the applicable period changed from the fiscal year ending September 2026 through the fiscal year ending September 2028, and the staged operating profit thresholds were raised to ¥2.0 billion, ¥2.3 billion and ¥2.5 billion. - FY2025-H1RestatedAnnual report
「In any fiscal year from the fiscal year ending September 2025 through the fiscal year ending September 2027, if the Company's operating profit meets any of the conditions set out in (a) through (c) below at least once, holders of the stock acquisition rights may exercise the granted stock acquisition rights up to the percentage specified for each item, referred to below as the "exercisable percentage."」
The performance-based conditions for the Series 7 Stock Acquisition Rights, based on operating profit of ¥1.3 billion, ¥1.6 billion and ¥1.7 billion for the fiscal years ending September 2025 through September 2027, continue to be stated. - FY2024RaisedAnnual report
「In any fiscal year from the fiscal year ending September 2025 through the fiscal year ending September 2027, if the Company's operating profit meets any of the conditions set out in (a) through (c) below at least once, holders of the stock acquisition rights may exercise the granted stock acquisition rights up to the percentage specified for each item. (a) If operating profit exceeds ¥1.3 billion: exercisable percentage of 30%; (b) if operating profit exceeds ¥1.6 billion: exercisable percentage of 80%; (c) if operating profit exceeds ¥1.7 billion: exercisable percentage of 100%.」
New Series 7 Stock Acquisition Rights were granted to 2 directors and 10 employees, with operating profit thresholds of ¥1.3 billion, ¥1.6 billion and ¥1.7 billion established as staged exercise conditions for the fiscal years ending September 2025 through September 2027. - FY2024-Q1First statedAnnual report
「If, during any fiscal year from the fiscal year ending September 2024 through the fiscal year ending September 2026, the Company’s operating income exceeds any of the thresholds set out in (a) through (c) below at least once, holders of the stock acquisition rights may exercise the granted stock acquisition rights up to the percentage specified for each item (the “exercisable percentage”). (a) If operating income exceeds ¥640 million: exercisable percentage of 15%; (b) if operating income exceeds ¥740 million: exercisable percentage of 50%; (c) if operating income exceeds ¥860 million: exercisable percentage of 100%.」
Stock acquisition rights have been granted to directors and employees, with the exercisable percentage increasing in stages according to operating profit levels from the fiscal year ending September 2024 through the fiscal year ending September 2026.